Latest News for: lmna

Edit

Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy

PR Newswire 08 Oct 2026
... (LMNA DCM) ... Nuevocor's lead clinical candidate, NVC-001, is being developed for LMNA-related dilated cardiomyopathy (LMNA DCM), one of the most aggressive forms of dilated cardiomyopathy.
  • 1

Article Search

tools
×
×
×
×